Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41577-020-0312-7 http://scihub22266oqcxt.onion/10.1038/s41577-020-0312-7 32296135!7186927!32296135     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32296135.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Nat+Rev+Immunol 2020 ; 20 (5): 271-272 Nephropedia Template TP {{tp|p=32296135|t=2020. COVID-19: risk for cytokine targeting in chronic inflammatory diseases?|pdf=|usr=}}{{32296135}} gab.com Text COVID-19: risk for cytokine targeting in chronic inflammatory diseases JO: Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32296135 #FOAvip COVID-19, caused by the SARS-CoV-2 virus, has become pandemic. With sharply rising infection rates, patient groups characterized by an enhanced infection risk will be challenged by the virus. In this context, patients with chronic immune-mediated inflammatory diseases are of particular interest, as these diseases are characterized by an intrinsic immune dysfunction leading to inflammation that may enhance risk for severe infection. Twit Text FOAVip COVID-19: risk for cytokine targeting in chronic inflammatory diseases ????Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32296135 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32296135 #FOAvip English Wikipedia <ref>{{Cite pmid|32296135}}</ref> COVID-19: risk for cytokine targeting in chronic inflammatory diseases? #MMPMID32296135 Schett G; Sticherling M; Neurath MF Nat Rev Immunol 2020[May]; 20 (5): 271-272 PMID32296135show ga COVID-19, caused by the SARS-CoV-2 virus, has become pandemic. With sharply rising infection rates, patient groups characterized by an enhanced infection risk will be challenged by the virus. In this context, patients with chronic immune-mediated inflammatory diseases are of particular interest, as these diseases are characterized by an intrinsic immune dysfunction leading to inflammation that may enhance risk for severe infection. |COVID-19[MESH] |Coronavirus Infections/*complications/drug therapy/immunology[MESH] |Cytokines/*antagonists & inhibitors/immunology[MESH] |Humans[MESH] |Immune System Diseases/*complications[MESH] |Inflammation/complications[MESH] |Pandemics[MESH]COVID-19: risk for cytokine targeting in chronic inflammatory diseases(epmc).pdf DeepDyve Pubget Overpricing